Sotera Health Company (SHC)

Sotera Health Company Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	315.95	346.46	278.87	301.65	396.29	106.92
Cash & Short-Term Investments	315.95	346.46	278.87	301.65	396.29	106.92
Cash Growth	3.22%	24.24%	-7.56%	-23.88%	270.63%	4.36%
Accounts Receivable	137.26	139.33	140.33	147.7	118.48	108.18
Other Receivables	6.31	8	6.66	5.73	12.09	4.64
Total Trade Receivables	143.56	147.33	146.98	153.43	130.58	112.83
Inventory	57.49	54.38	49.16	48.32	37.15	54.29
Other Current Assets	68.97	65.25	51.03	53.85	81	71.92
Total Current Assets	585.97	613.41	526.04	557.24	645.01	345.96
Net Property, Plant & Equipment	1,176	1,164	1,064	970.95	801.01	690.74
Other Intangible Assets	279.36	288.23	317.65	416.32	491.27	598.84
Goodwill	1,098	1,103	1,081	1,111	1,102	1,120
Long-Term Investments	-	-	-	-	-	9.41
Other Long-Term Assets	96.59	94.36	82.44	74.72	78.65	24.23
Total Assets	3,236	3,263	3,072	3,130	3,118	2,790

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	76.69	77.96	55.1	71.04	74.14	72.87
Accrued Expenses	85.63	124.74	90.46	122.47	490.13	61.86
Current Portion of Long-Term Debt	13.98	13.97	14.8	4.8	197.12	-
Current Portion of Leases	9.37	9.22	7.98	14.71	9.28	10.45
Unearned Revenue	13.74	18	15.1	13.49	12.14	8.67
Other Current Liabilities	8.4	5.69	7.56	4.15	8.76	7.31
Total Current Liabilities	207.8	249.58	191	230.65	791.57	161.16
Long-Term Debt	2,124	2,127	2,208	2,224	1,747	1,744
Long-Term Leases	122.58	123.74	119.75	83.88	78.53	73.89
Other Long-Term Liabilities	158.68	157.11	147.88	148.48	150.25	224.82
Total Long-Term Liabilities	2,406	2,408	2,476	2,456	1,976	2,042
Total Liabilities	2,613	2,657	2,667	2,687	2,767	2,203

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	2.86	2.86	2.86	2.86	2.86	2.86
Treasury Stock	-12.1	-17.01	-23.43	-27.18	-29.78	-33.55
Additional Paid-in Capital	1,263	1,262	1,244	1,215	1,190	1,173
Accumulated Other Comprehensive Income	-125.94	-109.84	-208.25	-92.68	-106.65	-83.57
Retained Earnings	-505.5	-532.09	-610.04	-654.44	-705.82	-472.25
Total Common Shareholders' Equity	622.51	606.04	404.91	443.73	350.24	586.1
Shareholders' Equity	622.51	606.04	404.91	443.73	350.24	586.1
Total Liabilities & Equity	3,236	3,263	3,072	3,130	3,118	2,790

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	2,270	2,274	2,351	2,327	2,032	1,828
Net Cash (Debt)	-1,954	-1,927	-2,072	-2,025	-1,636	-1,721
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-6.81	-6.73	-7.27	-7.15	-5.84	-6.16
Book Value	622.51	606.04	404.91	443.73	350.24	586.1
Book Value Per Share	2.17	2.12	1.42	1.57	1.25	2.10
Tangible Book Value	-754.49	-785.42	-993.82	-1,084	-1,243	-1,133
Tangible Book Value Per Share	-2.63	-2.74	-3.49	-3.83	-4.44	-4.06

SEC Filings: 10-K · 10-Q

Data Source: Fiscal.ai Last updated: May 5, 2026

Financial data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 28, 2026

Data Sources Report a data error